DR.
GREG BROWER, D.V.M., Ph.D. |
| |
Current: |
| |
|
|
R01HL62228 Janicki (PI) |
7/1/1999 - 4/30/2008 |
|
NIH/NHLBI |
Cardiac Mast Cell:
Role in Pathogenesis of Heart Failure |
| The major goal of
this grant is to investigate the contribution
of cardiac mast cells to the pathologic ventricular
remodeling which precedes the development of heart
failure. |
Role: Co-Investigator |
|
|
| |
|
|
| R01HL73990
Janicki (PI) |
7/1/2004
- 5/31/2008 |
|
NIH/NHLBI |
Sexual Hormones,
Cardiac Mast Cells and Cardioprotection |
| The major goal of
this grant is to investigate estrogen's modulation
of tumor necrosis factor-alpha production and
release from cardiac mast cells. |
Role: Co-Investigator |
|
|
| |
Previous: |
| |
|
|
| R01HL59981
Janicki (PI) |
1/1/1999
- 12/31/2003 |
|
NIH/NHLBI |
Role of Myocardial
Integrins in Ventricular Remodeling. |
| The major goal
of this grant is to investigate the relationship
between myocardial integrins and the extracellular
matrix in the ventricular remodeling resulting
in the transition to heart failure. |
Role: Co-Investigator |
|
|
| |
|
| EPA
RD831953 Brower (PI) |
9/1/2004
- 8/31/2007 |
|
Environmental
Protection Agency |
Mast Cell Mediated
Cardiovascular Effects of Particulate Matter. |
| The principle objective
of this grant is to elucidate the contribution
of cardiac mast cells to the increased morbidity/mortality
from heart failure induced by exposure to air
pollution. |
Role: Principal
Investigator |
|
|
| |
|
| EPA
RD831953 Brower (PI) |
9/1/2004
- 8/31/2007 |
|
Environmental Protection
Agency |
Mast Cell Mediated
Cardiovascular Effects of Particulate Matter. |
| The principle
objective of this grant is to elucidate the
contribution of cardiac mast cells to the increased
morbidity/mortality from heart failure induced
by exposure to air pollution. |
Role: Co-Investigator |
|
|
| |
|
|
1R01HL073990 Janicki (PI) |
7/1/2004 - 5/31/2008 |
|
NIH/NHBLI |
Sexual hormones,
Cardiac Mast Cells and Cardioprotection. |
| The goal of this
grant is to investigate gender differences in
cardiac mast cell activation pathways, including
TNF-alpha, and how these differences affect pathologic
ventricular remodeling. |
Role: Co-Investigator |
|
|
| |
Pending: |
| |
DR.
DAVID MURRAY, Ph.D. |
| |
Current: |
| |
|
| Murray
(PI) |
4/1/2006 - 2/28/2007 |
|
University of
South Carolina School of Medicine |
Inhibition of
Diabetic Remodeling. |
| Research and Productive
Scholarship Award, University of South Carolina
School of Medicine. Category 1. Mentored Career
Development. |
Role: PI |
|
|
| |
| Previous: |
| |
|
| #5-2006-916
Murray (PI) |
10/1/2006 - 10/1/2007 |
|
Juvenile Diabetes
Research Foundation |
Effects of PPAR
Agonists on Diabetes Induced Ventricular Fibrosis
|
| 1 year non renewable |
Role: PI |
|
|
| |
|
| 0325228B
Murray (PI) |
7/1/2003 – 6/30/2005 |
|
American Hear
Association Postdoctoral Fellowship |
Contribution of
endothelin-mediated cardiac remodeling to the
development of congestive heart failure. |
| 2 year salary only
project. |
Role: PI |
|
|
| |
| |
| Murray
(PI) |
4/1/2003 – 12/1/2005 |
|
Diabetes Trust
Foundation Project |
Contribution of
Endothelin-mediated Cardiac Remodeling to the
Development of Congestive Heart Failure in Diabetes.
|
| 2 year project supply
cost. |
Role: PI |
|
|
| |
|
| Murray
(PI) |
9/1/2006 – 6/30/2006 |
|
Centers of Biomedical
Research Excellence ( COBRE) Center for Cardiovascular
Research University of South Carolina School
of Medicine |
Cardiac Fibroblasts
and RAGE Signaling in Diabetic Cardiomyopathy.
|
| 6-8 month project
supply cost. |
Role: PI |
|
|
| |
Pending
Funding : |
| |
| DR.
SCOTT LEVICK, Ph.D. |
| |
| Current: |
| |
| |
|
Levick SP (PI) |
5/1/2007-4/30/2008 |
|
Philip Morris External
Research Postdoctoral Fellowship |
The Effect of Smoke
Exposure on the Early Stages of Left Ventricular
Remodeling. |
| |
Role: PI |
|
|
| |
| |
|
Levick SP (PI) |
7/1/2008-6/30/2009 |
|
American Heart Associatioh
Postdoctoral Fellowship |
Neuropeptide Regulation
of Caridac Mast Cell-Mediated Myocardial Remodeling |
| |
Role: PI |
|
